Since the first case was confirmed on 5 October 2022, over 1400 suspected cases have been reported across the country, including 381 laboratory-confirmed cases and 17 deaths.
While the outbreak was initially confined to northern districts, it rapidly spread, with laboratory-confirmed cases now reported from all eight governorates and 18 out of 26 districts. Serotype Vibrio cholerae O1 El-Tor Ogawa was identified as the currently circulating cholera strain, similar to the one circulating in Syria.
“Cholera is deadly, but it’s also preventable through vaccines and access to safe water and sanitation. It can be easily treated with timely oral rehydration or antibiotics for more severe cases,” says Dr Abdinasir Abubakar, WHO Representative in Lebanon.
“The situation in Lebanon is fragile as the country already struggles to fight other crises – compounded by prolonged political and economic deterioration.”
WHO is joining with the Ministry of Public Health and other health partners to curb the evolving cholera outbreak. For instance, WHO and other humanitarian partners have supported the Ministry to develop a national cholera preparedness and response plan, outlining the most urgent response interventions required, while scaling up surveillance and active case-finding in hotspot areas.
Given the shortage of both health staff and medical supplies in the country, WHO has provided the two reference laboratories, three prisons and 12 hospitals designated for cholera treatment with laboratory reagents, treatment kits and rapid diagnostic tests, and deployed nurses and doctors as surge capacity to hospitals in the most affected areas. The procurement and prepositioning of additional cholera supplies are being also finalized.
Additionally, WHO is ensuring that proper clinical management practices, infection prevention and control, and cholera testing protocols are in place for the adequate referral of cases to the needed level of care. Over the past few weeks, WHO has supported a series of training sessions at central and peripheral levels to improve the early detection and reporting of suspected cases, enhance clinical management and raise awareness among the public and frontline health workers on cholera prevention and control.
Despite global shortages in cholera vaccine, WHO is supporting the Ministry of Public Health to secure 600,000 doses of cholera vaccine for the most vulnerable populations, including frontline workers, prisoners, refugees and their host communities. Additional efforts to ensure more doses are ongoing given the rapid spread of the outbreak.
The vulnerability of people in Lebanon is being exacerbated by the prolonged difficult economic conditions and limited access to clean water and proper sanitation across the country. The migration of health care workers, disrupted supply chains and unaffordable energy supply have severely weakened the response capacity of hospitals and primary health care facilities, which are now threatened by the growing outbreak and increasing caseloads.
“There is still an opportunity to limit the spread and impact of the outbreak by intensifying response interventions, including improving water and sanitation quality. We also need to raise awareness on how to prevent cholera infection so that we can lift the pressure off hospitals. The best way to prevent a cholera outbreak is to ensure people have access to clean water and appropriate sanitation and hygiene. In the long term, we need to scale up global vaccine availability as part of a holistic strategy to prevent and stop cholera outbreaks worldwide,” Dr Abubakar emphasizes.